A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese

Xu, 1999, A novel human apolipoprotein (apoM), J. Biol. Chem., 274, 31286, 10.1074/jbc.274.44.31286 Xu, 2004, Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects, J. Nutr. Biochem, 15, 579, 10.1016/j.jnutbio.2004.03.001 Duan, 2001, Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis, FEBS Lett., 499, 127, 10.1016/S0014-5793(01)02544-3 Wolfrum, 2005, Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis, Nat. Med., 11, 418, 10.1038/nm1211 Ni, 2007, Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese, Diabetes Metab. Res. Rev., 23, 21, 10.1002/dmrr.641 John, 1991, A rapid procedure for extracting genomic DNA from leukocytes, Nucleic Acids Res., 19, 408, 10.1093/nar/19.2.408 Marenberg, 1994, Genetic susceptibility to death from coronary heart disease in a study of twins, N. Engl. J. Med., 330, 1041, 10.1056/NEJM199404143301503 Nora, 1980, Genetic–epidemiologic study of early-onset ischemic heart disease, Circulation, 61, 503, 10.1161/01.CIR.61.3.503 Guneri, 2005, The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus, Int. J. Heart, 46, 889, 10.1536/ihj.46.889 Hirashiki, 2003, Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors, J. Am. Coll. Cardiol., 42, 1429, 10.1016/S0735-1097(03)01062-3 Baroni, 2003, Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD, BMC Med. Genet., 10, 4 Wiwanitkit, 2006, PIA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIIa and its correlation with myocardial infarction: an appraisal, Clin. Appl. Thromb./Hemost., 12, 93, 10.1177/107602960601200115 Yokota, 2000, Association of a T29–C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese, Circulation, 101, 2783, 10.1161/01.CIR.101.24.2783 Christoffersen, 2006, Isolation and characterization of human apolipoprotein M-containing lipoproteins, J. Lipid Res., 47, 1833, 10.1194/jlr.M600055-JLR200 Singh, 2002, Differential, tissue-specific, transcriptional regulation of apolipoprotein B secretion by transforming growth factor beta, J. Biol. Chem., 277, 39515, 10.1074/jbc.M205513200 Xu, 2004, Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells, Biochim. Biophys. Acta, 1683, 33, 10.1016/j.bbalip.2004.04.001 Xu, 2002, Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1 alpha on the expression of apolipoprotein M in HepG2 cells, Biochem. Biophys. Res. Commun., 292, 944, 10.1006/bbrc.2002.6755